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Abstract
Background: Diabetic foot infections are common, serious, and varied. Diagnostic and treatment strategies are
correspondingly diverse. It is unclear how patients are managed in actual practice and how outcomes might be
improved. Clarification will require study of large numbers of patients, such as are available in medical databases.
We have developed and evaluated a system for identifying and classifying diabetic foot infections that can be used
for this purpose.
Methods: We used the (VA) Diabetes Epidemiology Cohorts (DEpiC) database to conduct a retrospective
observational study of patients with diabetic foot infections. DEpiC contains computerized VA and Medicare
patient-level data for patients with diabetes since 1998. We determined which ICD-9-CM codes served to identify
patients with different types of diabetic foot infections and ranked them in declining order of severity: Gangrene,
Osteomyelitis, Ulcer, Foot cellulitis/abscess, Toe cellulitis/abscess, Paronychia. We evaluated our classification by
examining its relationship to patient characteristics, diagnostic procedures, treatments given, and medical
outcomes.
Results: There were 61,007 patients with foot infections, of which 42,063 were classifiable into one of our
predefined groups. The different types of infection were related to expected patient characteristics, diagnostic
procedures, treatments, and outcomes. Our severity ranking showed a monotonic relationship to hospital length of
stay, amputation rate, transition to long-term care, and mortality.
Conclusions: We have developed a classification system for patients with diabetic foot infections that is expressly
designed for use with large, computerized, ICD-9-CM coded administrative medical databases. It provides a
framework that can be used to conduct observational studies of large numbers of patients in order to examine
treatment variation and patient outcomes, including the effect of new management strategies, implementation of
practice guidelines, and quality improvement initiatives.
Background
Diabetic foot infections are common and serious. They
are diverse, and can range from cellulitis of a toe to
gangrene of the foot. Diagnostic and treatment strategies
are correspondingly varied. Thus, a very large study
w o u l db en e e d e dt oe v a l u a t eh o wt h e s ei n f e c t i o n sa r e
managed in actual practice and how outcomes might be
altered by different treatment strategies. The use of
computerized medical databases could address this
problem. Such databases often include very large num-
bers of patients and are an important and increasing
source of information for use in medical research. First,
however, applicable methods are needed to identify and
categorize patients with diabetic foot infections.
In this paper, we report the construction of a classifi-
cation system for diabetic foot infections that is unique,
in that it is expressly designed for use with ICD-9-CM
coded administrative data and is derived from a very
large number of patients. To our knowledge, no similar
system has been described. We have applied it to a data-
base that contains all diabetic patients in the Veterans
Health Administration (VHA), and have found support
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acteristics, treatments received, and outcomes, including
rehospitalization, amputation, transition to long-term
care, and death. We developed it in preparation for a
study of practice variation in antibiotic use, but it is
readily applicable to other investigations. It provides a
framework that can be used to conduct observational
studies of large numbers of patients in order to examine
treatment variation and patient outcomes, including the
effect of new management strategies, implementation of
practice guidelines, and quality improvement initiatives.
Methods
The Study Population and Source Data
This retrospective observational study was approved by
the Institutional Review Board (IRB) of the Edith Nourse
Rogers VA Medical Center in Bedford, Massachusetts. It
was conducted in the population of diabetic patients
receiving care from the Veterans Health Administration
(VA) from 1998 through 2004. Our data came from the
national VA Diabetes Epidemiology Cohorts (DEpiC), a
linked, computerized research database that serves as a
registry of virtually all VHA patients with diabetes. It
contains patient-level data on medical visits, pharmacy
and laboratory data, with diagnoses and procedures for
VA and non-VA care (from Medicare claims data)[1].
Identification of ICD-9 codes for diabetic foot infections
First we looked up alphanumeric diagnoses indicative of
diabetic foot infections in the “index to diseases and
injuries” of the ICD-9-CM coding manual. This index
serves to “map” various alphanumeric diagnoses to their
ICD-9-CM codes[2]. Then we reviewed the formal defi-
nitions of these ICD-9-CM codes to confirm that they
did indeed indicate foot infection. We also examined
the definitions of related codes sharing the same initial
three-digit root. In addition, we used ICD-9 procedure
codes and CPT-4 codes to identify patients with ampu-
tation (see appendix for codes). We then examined all
the ICD-9-CM codes that had been assigned to these
patients in the 90 days before the amputation code
appeared in the database. We expected that codes for
foot infection would appear, because foot infections are
a frequent cause of amputation. Finally, we classified the
resulting ICD-9-CM codes for foot infection into two
groups, specific and moderately specific.
Specific codes for foot infection included all codes for
osteomyelitis, cellulitis/abscess, paronychia, ulcer, and
gangrene. We included the general codes for foot ulcers
because 58%-68% of such ulcers are associated with
active infection[3,4]. Likewise, we included the general
codes for gangrene even though they do not specify
whether it is infectious in cause, because infectious
gangrene is such an important and serious condition.
W ea l s oi n c l u d e dt h ec o d ef o rg a sg a n g r e n e( w h i c hi s
always infectious). The codes for osteomyelitis, cellulitis/
abscess, paronychia, ulcer, and gangrene all have sub-
codes that permit definite or highly presumptive locali-
zation to the foot. The exception is the code for gas
gangrene, but on subsequent analyses patients with this
code did not differ significantly in characteristics or out-
comes from the other patients with gangrene.
Moderately specific codes were those for open wounds
of the foot and infections of the leg (which we included
to be comprehensive because the latter can sometimes
arise by extension from the foot).
We were conservative in our choice of codes and
eliminated those that either did not indicate the location
of infection or allow the location to be confidently
inferred. We did this to maximize the specificity of our
codes for diabetic foot infections. Examples of codes
that we did not include are 681.9, “Infection or abscess
of unspecified digit,” and 707.8, “Chronic ulcer of other
unspecified sites.” See the appendix for our final list of
ICD-9-CM codes.
Use of ICD-9-CM codes to classify diabetic foot infections
Patients may have coexisting foot infections of different
types. This raises the question of how they should be
classified. We reasoned that the most severe of the
infections would determine the strength of association
with clinical outcomes, such as length of hospital stay,
amputation rate, transition to long-term care, and mor-
tality. Therefore, we ranked the infections in a presump-
tive order of severity and assigned the infection to the
most severe category for which they had an ICD-9-CM
code. Our presumptive order was Gangrene > Osteo-
myelitis > Foot ulcer > Cellulitis/abscess of foot > Cellu-
litis/abscess of toe > Paronychia. This was based on
clinical judgment, but corresponds in part to Wagner’s
classification system for diabetic foot ulcers, which
ranks ulcers with gangrene > ulcers with osteomyelitis,
> ulcers alone[5,6]. To improve the homogeneity of the
groups, we eliminated from each those patients who had
only moderately specific codes for more severe types of
infection. Figure 1 shows the flow of patients through
this process, the numbers that were classified into each
group, and the types of infections among those that
remained unclassified.
We assumed that patients were under treatment for
diabetic foot infection while in the hospital if, during that
hospitalization, they were assigned an ICD-9-CM code
for any of the foregoing types of diabetic foot infection.
Characteristics and treatment of patients with diabetic
foot infections
We described patients in terms of demographics, com-
plications of diabetes, and co-existing medical
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file entries for inpatient stays and outpatient visits span-
ning the years of available data (1987-2004). Complica-
tions of diabetes and other co-existing medical
conditions were identified from ICD-9-CM codes in
inpatient and outpatient records in the two-year period
prior to the first hospitalization in our database that had
an ICD-9-CM code for foot infection. Codes used were
determined by VA clinicians using published evaluations
whenever available. Cerebrovascular disease was identi-
fied with an algorithm evaluated in VA with cases con-
firmed by chart review and found to have high
sensitivity (92%), albeit with moderate specificity (40%)
[7,8]. On the other hand, the chronic kidney disease
codes have low sensitivity (20%-42%) but high specificity
(93%-99%) when compared with laboratory measures[9].
The codes for myocardial infarction also have high spe-
cificity[10].
Treatment during first identified hospitalization for foot
infection
We listed all ICD-9-CM diagnosis and ICD-9 procedure
codes that occurred for 1% or more of inpatients with
foot infection. We eliminated those that were not surgi-
cal in nature, did not carry anaesthetic risk or that were
not needed for DRG assignment, because such proce-
dures are not required to be coded according to current
guidelines. For amputations, we grouped all amputation
codes and report the number of patients with any such
code. (See the appendix for specific codes.)
Outcomes of patients with diabetic foot infections
Rehospitalization for foot infection
Using ICD-9-CM codes and our classification system,
we determined: 1) The proportion of patients who were
rehospitalized for any type of foot infection; 2) The type
of foot infection that was present; and, 3) The number
of days between admissions.
Long-term outcomes
Long-term outcomes were amputation rate, transition to
long-term care, and death. We included long-term care
because serious disease of the lower extremity might
result in impaired ambulation and a need for nursing
home care in older patients–a phenomenon that has
been observed in patients who have had surgery for hip
fracture[11]. We included death because of the high fre-
quency of co-morbid vascular disease, which is a predis-
posing factor for serious foot infections.
Subsequent amputations were identified by ICD-9
procedure codes from inpatient records. We also identi-
fied past amputation using the ICD-9 procedure codes
along with ICD-9-CM diagnosis and CPT-4 procedure
codes for post-amputation and prosthesis care; we used
this broader definition because it is more sensitive in
identifying amputations, including those that may have
occurred outside of the VA[12,13].
Long-term care was identified from outpatient, inpati-
ent, extended care, and fee basis files. The first three
types of files provide information on VA long-term care.
The last type provides records of community-based
non-VA long-term care charged to the VA. Unfortu-
nately, we do not have information on other commu-
nity-based non-VA long-term care. Long-term care
includes both inpatient (i.e. nursing home) and outpati-
ent (home health and/or skilled nursing) care.
Deaths were identified from DEpiC, which assigns
death based on an algorithm using information from the
All patients with inpatient
codes for diabetic foot infection
N=61,007
YES NO
Gangrene Is there a code for 
N=11,666 Gangrene ? 49,341
YES NO
Osteomyelitis Is there a code for 
N=4,133 Osteomyelitis ? 45,208
YES NO
Ulcer Is there a code for 
N=20,142 Ulcer? 25,066
YES NO
Cellulitis or Is there a code for 
Abscess Cellulitis or Abscess 
of the Foot  of the Foot ?
N=4,438 20,628
YES NO
Cellulitis or Is there a code for 
Abscess Cellulitis or Abscess 
of the Toe  of the Toe ?
N=1,395 19,233
YES NO
Paronychia Is there a code for 
N=289 Paronychia ?
Only other 
Other codes 
N=18944
N=119 Other gangrene
N=908 Other osteomyelitis*
N=1,321 Other ulcer*
N=15,921 Other cellulitis*
N=675 Other 
* of lower limbs not specific to foot.
Figure 1 VA patients with foot infections: classification to
group. * Of lower limbs, not specific to foot.
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system (BIRLS) file, VA inpatient records, the Social
Security Death Index, and Medicare records. The com-
bination of these records has a sensitivity of 98%[14].
Statistical analyses
We used the Cochrane-Armitage test of trend to deter-
mine whether there was a statistically significant graded
relationship between our severity ranking and clinical
outcomes. We used a Bonferroni adjustment for multi-
ple comparisons applied to an alpha of 0.05[15].
Results
Counts and classification of patients with diabetic foot
infections
We identified 61,007 patients with one or more specific
or moderately-specific codes for diabetic foot infection
in inpatient records. Of these, 42,063 (68.9%) had speci-
fic codes that were classifiable into one of our prede-
fined groups. Thirty-three percent of all patients had
ulcer, 19.1% gangrene, 7.3% cellulitis or abscess of the
foot, 6.8% osteomyelitis, 2.3% cellulitis or abscess of the
toe, and 0.5% paronychia. As shown in figure 1, we clas-
sified the remaining 18,944 patients (31.1%) as having
various “other” types of infection. This “other” category
consisted almost entirely of patients with ICD-9-CM
codes for infection of the leg but not specifically of the
foot. For example, 84% of them had codes for cellulitis
of the leg. They are included in our sample because
infection of the foot can extend into the leg but they are
not included in the evaluation of our classification
system.
Proportions of patients with co-existing infections
The types and proportions of co-infections are shown in
Table 1. By definition, patients with a given infection
cannot have any co-existing infections that are more
severe, but may have those that are less severe.
Demographics, diabetic complications, and other co-
morbidities of patients with different types of infection
The demographic characteristics and diabetic complica-
t i o n so fp a t i e n t sw i t hd i f f e r e n tt y p e so ff o o ti n f e c t i o n
are shown in Table 2. African-Americans tended to
have more severe infections. The exception to this was
in patients with paronychia. Because of its mild nature,
patients with this condition would almost certainly be
admitted to hospital for other reasons. This affects their
demographics and other factors, such as length of stay,
hospital procedures, and co-morbid conditions. Patients
with gangrene were older than those with other types of
infection.
Table 2 also shows that the prevalence of diabetic
complications varies with our classification of diabetic
foot infections. Patients with gangrene have the highest
prevalence of peripheral vascular disease while patients
with the mildest infection, paronychia, have the lowest
prevalence of peripheral vascular disease and also dia-
betic eye disease. Patients with osteomyelitis and ulcer
have the highest prevalence of neuropathy and the low-
est prevalence of cerebrovascular disease and myocardial
infarction.
We also examined the prevalence of 33 additional
physical co-morbidities and 7 mental co-morbidities
(data not shown). It was apparent that diabetic patients
Table 1 Coexisting Infections in Patients hospitalized for Diabetic Foot Infections
Group
Coexisting infections Gangrene Osteomyelitis Ulcer Foot
Cellulitis
or Abscess
Toe
Cellulitis
or Abscess
Paronychia
11,666 4,133 20,142 4,438 1,395 289
Gangrene -- - - - -
Osteomyelitis <1 % - - - - -
Ulcer 17.2% 25.0% - - - -
Foot cellulitis/abscess 16.0% 23.5% 17.6% - - -
Toe cellulitis/abscess < 1% 11.6% < 1% < 1% - -
Paronychia <1 % <1 % <1 % <1 % <1 % -
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blems: for example, hypertension (83.2%), obstructive
chronic bronchitis (48.4%), congestive heart failure
(39.4%), depression (37.8%) and cancer (33.8%).
Length of hospital stay and treatments received
Table 3 summarizes length of stay and shows the pro-
portion of patients with various treatments for each of
our patient groups. There are a number of trends that
correspond to the severity ranking embedded in our
classification system. Most notably, the median length of
stay decreases progressively from gangrene to cellulitis
of the toe. Trends of increasing treatment with increas-
ing severity are also present for any current amputation
and any past amputation. When the trends are not
entirely monotonic, the deviation is slight and occurs at
the milder end of our severity ranking.
As expected, patients with different types of infection are
identified as having different types of procedures. Those
with cellulitis or abscess of the foot or toe most commonly
have incision and drainage, while those with osteomyelitis
most commonly have excisional debridement. Patients
with gangrene undergo vascular radiographic studies and
have amputation more frequently than others.
The table also shows that patients with paronychia have
a length of stay disproportionately long for such a mild
infection. They also have a more than two-fold increase in
the prevalence of alcohol addiction and psychiatric treat-
ment compared to the other patient groups (data for the
latter two not shown). These findings are concordant with
the likelihood that paronychial infection developed while
the patient was in hospital for other reasons.
Outcomes post-discharge
Rehospitalization for foot infection
A total of 24,297 patients (39.8%) had readmission for
any type of foot infection over the 6-year time span of
our database.
Patients initially hospitalized with the most severe
types of infection were most often readmitted for the
same problem (28% of those with gangrene, 25% of
those with ulcer, 17% of those with osteomyelitis).
Those initially hospitalized with milder types of infec-
tion were more commonly readmitted with more severe
infections, particularly ulcer (cellulitis/abscess of the
foot 12%, cellulitis/abscess of the toe 11%, paronychia
6%). The shortest time to readmission was for recur-
rence of the same type of infection for all types of initial
infection other than ulcer. Ulcer patients returned ear-
liest for gangrene, but next earliest for ulcer itself.
Rates of amputation, transition to long-term care, and death
Table 3 shows the proportions of each type of infection
with amputation, transition to long-term care, and death
in the year after discharge.
Table 2 Demographics and Diabetic Complications of Patients with Hospitalization for Diabetic Foot Infection
Group
Any Gangrene Osteomyelitis Ulcer Foot
Cellulites
or Abscess
Toe
Cellulitis
or Abscess
Paronychia Other
61,007 11,666 4,133 20,142 4,438 1,395 289 18,944
Male 98.5% 99.1% 98.9% 98.6% 98.4% 98.4% 96.9% 98.0%
Mean Age 68.1 70.0 66.3 68.7 66.9 67.3 66.7 66.9
Standard deviation 11.0 10.2 11.0 10.9 11.4 11.4 12.6 11.3
White 76.3% 68.0% 75.1% 77.9% 76.6% 81.1% 76.6% 79.7%
African-American 16.0% 23.1% 17.5% 15.7% 14.3% 12.0% 17.4% 12.1%
Other race 7.7% 8.9% 7.4% 6.4% 9.1% 6.9% 6.0% 8.2%
Unknown 3.5% 3.1% 6.2% 3.1% 2.9% 3.3% 2.4% 3.7%
Peripheral vascular disease 66.9% 77.2% 71.5% 73.8% 58.4% 64.6% 55.7% 54.6%
Peripheral neuropathy 53.4% 55.6% 62.7% 59.9% 55.5% 58.1% 49.5% 42.5%
Diabetic eye disease 43.2% 48.9% 48.7% 47.3% 41.4% 46.5% 34.3% 34.2%
Cerebrovascular diseases 24.3% 29.2% 19.2% 26.1% 21.2% 24.7% 27.7% 21.0%
Myocardial infarction 22.5% 24.0% 17.0% 22.7% 20.5% 22.2% 23.5% 23.0%
Renal diseases 20.6% 26.2% 16.9% 22.1% 17.0% 18.5% 19.4% 17.5%
Text in large, bold, italic font shows findings that correspond to clinical expectation (see discussion).
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(13.1%) had new ICD-9-CM codes for lower leg amputa-
tion at any time after their first hospitalization. Of these,
7.8% had an amputation within one year, with more
than half (4.8%) occurring within 90 days. Amputation
rates declined progressively with declining severity of
initial infection, the only exception being patients with
toe cellulitis/abscess (p < 0.001).
We examined transition to long-term care in the
47,582 patients (78.0%) that had no prior long-term
care. Of these, 8.7% had subsequent inpatient (i.e. nur-
sing home) long-term care within a year and for more
than half of them (5.1%) this occurred within 90 days.
As with amputation, transition to long-term care
showed a progressive decline with decreasing severity of
the initial infection (p < 0.001).
A total of 21,074 of the 61,007 patients (34.5%) with
diabetic foot infection died after discharge. Roughly half
this total (17% of patients) died within one year of hos-
pital discharge and roughly half of those patients (8.8%)
died within 90 days. Those with gangrene had the great-
est risk. Though the trend in mortality in relation to our
severity ranking is statistically significant, it is mostly
driven by the very high mortality in patients with
gangrene.
Discussion
A number of classification systems for diabetic foot
infections have been developed, but none of them was
designed for use with ICD-9-CM coded administrative
data[6,16-22]. In addition, those that consider infection
do so in the context of a co-existing diabetic foot ulcer.
This is understandable, since foot ulcers are by far the
most common antecedent of infection[23]. In contrast,
we have designed our classification system expressly for
use with ICD-9-CM coded data, and have included
infections that may sometimes occur in the absence of
ulcer.
Our classification is made up of six mutually exclusive
types of infection. This is obligatory for comparing one
type of infection to another in relation to outcomes, uti-
lization of resources, and other matters of interest. Sub-
stantial numbers of patients, however, have more than
one kind of infection. We have addressed this by creat-
ing a hierarchy of severity. An important question is
whether our hierarchy is sound.
A number of findings support the validity of our
severity ranking. First, we have found that African-
Americans tended to have more severe infections, which
agrees with the known higher frequency of amputation
in non-whites[24]. Second, with minor exceptions, we
Table 3 Length of hospital stay and procedures of patients with hospitalization for diabetic foot infection
Group
Gangrene Osteomyelitis Ulcer Foot
Cellulitis
or Abscess
Toe
Cellulitis
or Abscess
Paronychia Other
11,666 4,133 20,142 4,438 1,395 289 18,944
Length of stay (days)
Median 14 10 7 6 5 66
Mean(SD) 31.1 (61.6) 28.5 (62.5) 20.0 (62.5) 12.6 (34.9) 15.2 (86.6) 27.8 (96.5) 13.9 (44.4)
Diagnostic studies
Arteriogram leg 12.7% 4.1% 5.8% 2.4% 3.3% 2.1% 1.6%
Aortogram 7.8% 2.6% 3.7% 1.6% 2.5% < 1% 1.2%
Treatments
Any current amputation 1.9% 1.5% 0.3% 0.3% 0.7% 0.0% 0.2%
Any past amputation 11.0% 5.7% 4.2% 2.0% 2.0% 1.4% 1.7%
Excisional debridement 3.5% 5.4% 3.8% 2.0% 2.1% 1.4% 1.0%
Skin/subcutaneous I & D 1.2% 2.5% 1.6% 3.9% 3.8% 2.8% 3.0%
Outcomes at 1 year
Amputations 18.8% 10.0% 7.7% 4.2% 5.4% 1.7% 1.8%
Long-term care 16.5% 14.6% 11.1% 10.5% 8.2% 7.9% 8.6%
Death 24.4% 12.5% 19.3% 11.5% 12.0% 14.9% 13.2%
Rows with large bold font show statistically significant trends after correction for multiple comparisons. Cells with large bold italic font show findings that
correspond to clinical expectation (as considered in discussion).
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our scale to hospital length-of-stay, past amputation,
current amputation, subsequent amputation, and transi-
tion to long-term care. These findings are consonant
with those of Pittet, in a study of foot ulcers. He found
failure rates of treatment in 93% in patients who had an
ulcer accompanied by gangrene, 30% when accompanied
by osteomyelitis, and 19% in the remainder[5]. It is to
be expected that infections that are more difficult to
treat will increase the duration of hospitalization, raise
the rates of amputation, and result in a greater need for
long-term care.
These findings corroborate our severity ranking. They
also confirm our ability to categorize infections cor-
rectly, because it would not be possible to create a
workable ranking otherwise. There is additional support
in our finding that the shortest time to readmission was
for the same type of infection, with longer intervals for
new types of infection. Further evidence derives from
the relationship of our categories of infection to
expected patient characteristics and treatments. Thus,
gangrene, which is related to vascular insufficiency,[25]
has the highest prevalence of peripheral vascular disease
as well as a higher frequency of vascular radiographic
studies. Likewise, both ulcer and osteomyelitis have a
higher frequency of peripheral neuropathy, with which
they are known to be associated[23]. Osteomyelitis com-
plicates severe neuropathic ulcers, which can occur
independently of macrovascular disease[26]. As
expected, patients with osteomyelitis are more often are
treated with excisional debridement, which is particu-
larly indicated for removal of infected bone[23]. Celluli-
tis/abscess of the foot and toe were treated more often
than other infections with incision and drainage.
The foregoing findings support the validity of our diag-
nostic categories and our severity ranking. The differ-
ences that we have found between types of infection,
h o w e v e r ,a r es o m e t i m e ss m a l l .T h e r ea r ean u m b e ro f
possible reasons for this. First, a significant number of
our patients have co-existing infections, which would
tend to blur distinctions among them. Second, if a patient
received an ICD-9-CM code for foot infection during a
hospitalization we have presumed that the infection was
under treatment, but that was not necessarily the case.
Third, there is the likelihood of undercoding and miscod-
ing of diagnoses and treatments. This is a recognized
problem in dealing with data derived from administrative
records[27-29]. There is evidence that it has occurred in
this study as well. For example, osteomyelitis had a sig-
nificantly higher rate of excisional debridement com-
pared to other infections, but the absolute increase in
percentage was only 1.5. Undercoding occurs much less
often for major co-morbidities, treatments and outcomes,
however[30]. The percentage of ulcer patients in our
study with amputation or death, for example, is compar-
able to the findings in other investigations[31,32].
Another limitation is that we do not have measures of
severity within each category of infection. Other studies
have demonstrated that gradations of severity in foot
ulcers have an effect on outcomes[22,33,34]. Our classi-
fication can address this, however, if patients with ulcers
are stratified according to whether they also have gang-
rene, osteomyelitis, or neither. This approach approxi-
mates the severity ranking created by Wagner[6]. Most
such rankings, though, use clinical data that are not
often present in computerized databases, such as size,
depth, and signs of inflammation. This may change in
the future. The data available in such databases are
increasing and one database already exists that contains
information about ulcer size and grade[35]. Such infor-
mation can be incorporated into our classification as it
becomes available.
We also presumed gangrene and foot ulcers to be
infected, but this is not always the case. Where this is a
concern, it can be addressed by restricting analyses to
patients where infection is definite, as is the case when
there is gas gangrene, osteomyelitis, cellulitis, or abscess.
Last, we have only applied statistical tests of signifi-
cance to our trend analyses, because we considered
them in designing the study as a hypothetical way to
test the hierarchical order of infections in our classifica-
tion system. The remaining observations are descriptive
so we do not present results of statistical tests.
Despite the foregoing limitations, we have succeeded
in showing that useful information can still be obtained,
because we can distinguish different patterns of care
and outcomes related to the particular infections that
we have identified. In addition, the picture of diabetic
foot infections that has emerged is consistent with that
derived from investigations of foot ulcers, which are the
most common predecessor of foot infection[23]. The
findings in this study that correspond to the observa-
tions of others include: 1) A tendency for infections to
be both recurrent and progressive, which is evident in
our data on rehospitalization, and which fits with the
known tendency of foot ulcers to persist and advance
over time;[31,36] 2) The relationships of gangrene with
peripheral vascular disease[25] and of peripheral neuro-
pathy with foot ulcers and osteomyelitis;[23] 3) Progres-
sively higher amputation rates in relation to ulcer,
osteomyelitis, and gangrene;[5,33] and 4) The associa-
tion of our infections with high short-term mortality,
probably related to the high prevalence of co-existing
macrovascular disease and other co-morbidities[32].
Beyond this, we have also contributed useful new infor-
mation on readmissions, as well as on rates of amputa-
tion, transition to long-term care and death as they
relate to patients with different categories of infection.
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literature. Other investigators have used ICD-9-CM
codes as a case-finding strategy to choose medical
records for manual review[37]. In one published study,
chart diagnoses were compared to ICD-9-CM codes and
were found to have a high sensitivity and specificity
(0.99 and 0.93, respectively)[38]. A more recent study
from Australia, however, showed much lower sensitivity
[39]. This divergence may reflect differences in coding
practices. This carries the implication that our classifica-
tion system needs to be confirmed in other systems of
care, and, depending on the findings, it is possible that
our choice of ICD-9-CM codes might need to be
modified.
Conclusions
We have developed a classification system for patients
with diabetic foot infections for use with large, compu-
terized, administrative medical databases. It is broadly
applicable, because it is based upon ICD-9-CM codes
that are in widespread use. If further validated in other
settings, it will provide a framework that can be used to
conduct observational studies of large numbers of
patients in order to examine factors that influence
patient outcomes, such as new treatments, implementa-
tion of practice guidelines, quality of care, and practice
variation.
Appendix
Codes for amputation involving the lower extremity
Current amputations (ICD-9 procedure codes):84.11-17
Past amputations (ICD-9-CM codes): V49.71-77; V52.1
(CPT-4 codes): 27888, 28800, 28801, 28802, 27803,
28804, 28805, 27290, 27598, 27880, 27881, 27882,
27884, 27885, 27886, 27590, 27591, 27592, 27290,
27291, 27292, 27293, 27294, 27295, 27594, 27595,
27596, 26910, 28810, 28811, 28812, 28813, 28814,
28815, 28816, 28817, 28818, 28819, 28820, 28821,
28822, 28823, 28824, 28825
Final set of ICD-9-CM codes for foot infection
Gangrene
040.0Gas Gangrene
440.24Atherosclerosis of the extremities with gangrene
785.4Gangrene but only if any one of the following is
also present:
250.7 Diabetes with peripheral circulatory disorders
440.2 Atherosclerosis of native arteries of the
extremities
Any condition classifiable to 440.21, 440.22, and
440.23
Osteomyelitis
730.07 Acute osteomyelitis of ankle and foot
730.17 Chronic osteomyelitis of ankle and foot
730.27 Unspecified osteomyelitis of ankle and foot
730.97 Unspecified infection of bone of ankle and foot
Ulcer
440.23 Atherosclerosis of the extremities with
ulceration
707.14 Ulcer of heel and mid foot
707.15 Ulcer of other part of foot
707.1 Ulcer of lower limbs
Cellulitis or abscess of foot
680.7 Carbuncle and furuncle of foot, heel, toe
682.7 Cellulitis and abscess of foot, except toes
Cellulitis or abscess of toe
681.1 Cellulitis and abscess of toe
681.10 Cellulitis, toe nos
Paronychia
681.11 Onychia and paronychia of toe
ICD-9-CM codes for complications of diabetes
Peripheral vascular disease: 250.7, 440, 443.8, 443.9,
785.4, 997.2
Peripheral neuropathy: 250.6, 357.2
Diabetic eye disease: 250.5, 362.0, 379.23
Cerebrovascular disease: 435 or [primary diagnosis =
430-432, 434, 436] OR
[V57.xx (rehab) AND secondary diagnosis = 342
(hemiparesis), 430-438] OR
[primary diagnosis = 433, 435 AND secondary diagno-
sis = 342, 430-432, 434, 436]
Myocardial infarction: 410, 411.0, 427.5
Renal disease: 585, 586, 996.73, 996.81, V42.0, V45.1
CPT-4 codes for treatments
Angiography, extremity: 75710, 75716
Aortography, abdominal, plus bilateral iliofemoral
lower extremity: 75630
Aortography, abdominal or thoracic: 75600, 75605,
75625
Debride tissue/muscle/bone: 11044
Incision and drainage of abscess: 10060, 10061, 20000,
20005
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